News
Biosimilars in the Prophylaxis of Venous Thromboembolism
Hospitalized patients with internal diseases or after surgery have an increased risk of venous thromboembolism (VTE). The first-line prophylaxis for patients at high risk of thrombosis with an acceptable risk of bleeding is anticoagulants from the low molecular weight heparin (LMWH) group.
46th annual European Hernia Society conference 2024
The 46th EHS annual conference 2024, held at the Prague Congress Centre from 29th to 31st May 2024,…
Technology allows children in palliative care to escape from the hospital room for a while
Children's palliative care is a field that is just developing in our country. Palliative teams are…
With MD Eva Drbohlavová on Innovations in the Treatment of von Willebrand Disease and Improving Patients' Quality of Life
Von Willebrand Disease (vWD), as the most common congenital bleeding disorder, remains…
Artificial Intelligence Helps Dentists Find Cavities or Create Implants
Just like in other fields of medicine, artificial intelligence (AI) has been experiencing a…
The Role of Inflammation in the Cardiovascular Continuum and the Aging Process
Inflammation plays a role at various stages of the cardiovascular (CV) continuum, in both…
Subcutaneous vs. Intravenous Immunoglobulins in Patients with CLL
Secondary antibody immunodeficiency is a common complication in patients with chronic lymphocytic…
Talking without vocal cords? A new AI-supported technology may help
A team of bioengineers from the University of California, Los Angeles (UCLA) has developed a thin,…
Bimekizumab in the treatment of moderate to severe hidradenitis suppurativa – another approved indication for this biological agent
In May, the primary results of the BE HEARD I and II studies evaluating the efficacy and safety of…
Reducing Overall Mortality by Combining Three Antihypertensives into a Single Pill
Treating hypertension to recommended target blood pressure values often requires a combination of…